Look for digital healthcare provider WELL Health Technologies to open up the M&A tap over the next couple of quarters, says Raymond James analyst Rahul Sarugaser, who maintained an Outperform rating in a Monday report.
Operator: Good day and thank you for standing by. Welcome to the Profound Medical First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Raymond James analyst Rahul Sarugaser is staying optimistic on Ginkgo Bioworks, saying in a Friday report it’s still early innings for the cell design company.
Québec-based specialty pharma company Medexus Pharmaceuticals received a target price increase from Raymond James on Thursday after securing a new bank debt.